• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Antiretroviral Therapy in Children and Adolescents: A Look Into Modern Single Tablet Regimens.儿童和青少年的抗逆转录病毒疗法:现代单片复方制剂剖析
J Pediatr Pharmacol Ther. 2021;26(8):783-794. doi: 10.5863/1551-6776-26.8.783. Epub 2021 Nov 10.
2
Relationship Between Single Tablet Antiretroviral Regimen and Adherence to Antiretroviral and Non-Antiretroviral Medications Among Veterans' Affairs Patients with Human Immunodeficiency Virus.退伍军人事务部人类免疫缺陷病毒患者中单片抗逆转录病毒疗法与抗逆转录病毒及非抗逆转录病毒药物依从性之间的关系
AIDS Patient Care STDS. 2017 Sep;31(9):370-376. doi: 10.1089/apc.2017.0081. Epub 2017 Aug 3.
3
Comparison of adherence rates for antiretroviral, blood pressure, or mental health medications for HIV-positive patients at an academic medical center outpatient pharmacy.比较在学术医疗中心的门诊药房,HIV 阳性患者对抗逆转录病毒、降血压或精神健康药物的服药依从率。
J Manag Care Spec Pharm. 2014 Aug;20(8):809-14. doi: 10.18553/jmcp.2014.20.8.809.
4
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.用于治疗符合抗逆转录病毒治疗条件的孕妇艾滋病毒感染的抗逆转录病毒疗法。
Cochrane Database Syst Rev. 2010 Mar 17(3):CD008440. doi: 10.1002/14651858.CD008440.
5
The Need for Pediatric Formulations to Treat Children with HIV.治疗感染艾滋病毒儿童所需的儿科制剂
AIDS Res Treat. 2016;2016:1654938. doi: 10.1155/2016/1654938. Epub 2016 Jun 16.
6
Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study.单片制剂与每日一次多片制剂作为一线抗逆转录病毒疗法的有效性和耐受性——一项大型法国多中心队列研究的结果
PLoS One. 2017 Feb 2;12(2):e0170661. doi: 10.1371/journal.pone.0170661. eCollection 2017.
7
Single-Tablet Regimens in HIV Therapy.HIV 治疗中的单片制剂方案。
Infect Dis Ther. 2014 Jun;3(1):1-17. doi: 10.1007/s40121-014-0024-z. Epub 2014 Feb 20.
8
Real-world adherence and persistence for newly-prescribed HIV treatment: single versus multiple tablet regimen comparison among US medicaid beneficiaries.新处方 HIV 治疗的真实世界依从性和持久性:美国医疗补助受益人群中单一片剂与多片剂方案比较。
AIDS Res Ther. 2020 Apr 1;17(1):12. doi: 10.1186/s12981-020-00268-1.
9
Adherence to HIV treatment regimens: systematic literature review and meta-analysis.艾滋病病毒治疗方案的依从性:系统文献综述与荟萃分析。
Patient Prefer Adherence. 2019 Apr 3;13:475-490. doi: 10.2147/PPA.S192735. eCollection 2019.
10
Strength in Amalgamation: Newer Combination Agents for HIV and Implications for Practice.融合的力量:新型 HIV 联合用药及其对实践的影响。
Pharmacotherapy. 2018 Jan;38(1):86-107. doi: 10.1002/phar.2055. Epub 2017 Dec 11.

引用本文的文献

1
Considerable variation in the 95-95-95 targets accomplishment between children and adults might delay achievement of set targets.儿童和成人在95-95-95目标达成方面存在相当大的差异,这可能会延迟既定目标的实现。
Front Public Health. 2025 Apr 29;13:1565242. doi: 10.3389/fpubh.2025.1565242. eCollection 2025.
2
Transition of adolescents from paediatric to adult HIV care in South Africa: A policy review.南非青少年从儿科艾滋病护理向成人艾滋病护理的过渡:一项政策审查。
South Afr J HIV Med. 2025 Apr 2;26(1):1674. doi: 10.4102/sajhivmed.v26i1.1674. eCollection 2025.
3
Pharmacokinetics, safety and efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in children with HIV aged from 2 years and weighing at least 14 kg.埃替拉韦/考比司他/恩曲他滨/替诺福韦艾拉酚胺在2岁及体重至少14千克的HIV感染儿童中的药代动力学、安全性和疗效。
J Int AIDS Soc. 2025 Feb;28(2):e26414. doi: 10.1002/jia2.26414.
4
Mapping the Transition of Adolescents to Adult HIV Care: A Mixed-Methods Perspective from the Cape Town Metropole, South Africa.描绘青少年向成人艾滋病病毒护理的过渡:来自南非开普敦都会区的混合方法视角
Trop Med Infect Dis. 2024 Dec 24;10(1):5. doi: 10.3390/tropicalmed10010005.
5
Risk Factors for Viral Non-suppression Among Youth Living with HIV in Nigeria: Findings from the iCARE Nigeria Study.尼日利亚感染艾滋病毒青年中病毒抑制未达标的风险因素:来自尼日利亚关爱研究的结果
AIDS Behav. 2025 Mar;29(3):848-857. doi: 10.1007/s10461-024-04565-y. Epub 2024 Dec 9.
6
Leading Paediatric Infectious Diseases-Current Trends, Gaps, and Future Prospects in Oral Pharmacotherapeutic Interventions.前沿儿科传染病——口服药物治疗干预的当前趋势、差距及未来前景
Pharmaceutics. 2024 May 26;16(6):712. doi: 10.3390/pharmaceutics16060712.
7
Caregivers of children with HIV in Botswana prefer monthly IV Broadly Neutralizing Antibodies (bNAbs) to daily oral ART.博茨瓦纳携带艾滋病毒儿童的照顾者更喜欢每月注射广泛中和抗体(bNAbs),而不是每天口服抗逆转录病毒药物。
PLoS One. 2024 Mar 27;19(3):e0299942. doi: 10.1371/journal.pone.0299942. eCollection 2024.
8
Follow-up for 3 years of a pediatric population diagnosed in 2018 with mother-to-child transmission of HIV in 8 Latin American countries in the PLANTAIDS cohort.对2018年在拉丁美洲8个国家的PLANTAIDS队列中诊断为母婴传播艾滋病毒的儿科人群进行了3年随访。
BMC Infect Dis. 2024 Feb 20;24(1):222. doi: 10.1186/s12879-024-09091-9.
9
Preparation and Characterization of 3D-Printed Dose-Flexible Printlets of Tenofovir Disoproxil Fumarate.制备并表征富马酸替诺福韦二吡呋酯 3D 打印剂量灵活的打印小片。
AAPS PharmSciTech. 2023 Aug 11;24(6):171. doi: 10.1208/s12249-023-02623-7.
10
Factors Associated With Viral Suppression and Drug Resistance in Children and Adolescents Living With HIV in Care and Treatment Programs in Southern Tanzania.坦桑尼亚南部关爱和治疗项目中接受治疗的 HIV 感染儿童和青少年病毒抑制和耐药相关因素分析。
J Pediatric Infect Dis Soc. 2023 Jun 30;12(6):353-363. doi: 10.1093/jpids/piad040.

本文引用的文献

1
Real-world adherence and persistence for newly-prescribed HIV treatment: single versus multiple tablet regimen comparison among US medicaid beneficiaries.新处方 HIV 治疗的真实世界依从性和持久性:美国医疗补助受益人群中单一片剂与多片剂方案比较。
AIDS Res Ther. 2020 Apr 1;17(1):12. doi: 10.1186/s12981-020-00268-1.
2
Prioritising the most needed paediatric antiretroviral formulations: the PADO4 list.优先考虑最需要的儿科抗逆转录病毒制剂:PADO4 清单。
Lancet HIV. 2019 Sep;6(9):e623-e631. doi: 10.1016/S2352-3018(19)30193-6.
3
Nonadherence and unsuppressed viral load across adolescence among US youth with perinatally acquired HIV.美国青少年艾滋病病毒母婴传播患者在青春期的不遵医行为和病毒载量未受抑制情况。
AIDS. 2019 Oct 1;33(12):1923-1934. doi: 10.1097/QAD.0000000000002301.
4
Optimizing Pediatric Dosing Recommendations and Treatment Management of Antiretroviral Drugs Using Therapeutic Drug Monitoring Data in Children Living With HIV.利用治疗药物监测数据优化儿童抗逆转录病毒药物的给药建议和治疗管理,以治疗 HIV 感染者。
Ther Drug Monit. 2019 Aug;41(4):431-443. doi: 10.1097/FTD.0000000000000637.
5
Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials.替诺福韦艾拉酚胺与富马酸替诺福韦二吡呋酯的肾脏安全性:26 项临床试验的汇总分析。
AIDS. 2019 Jul 15;33(9):1455-1465. doi: 10.1097/QAD.0000000000002223.
6
Variability of efavirenz plasma concentrations among pediatric HIV patients treated with efavirenz based combination antiretroviral therapy in Dar es Salaam, Tanzania.在坦桑尼亚达累斯萨拉姆接受基于依非韦伦的联合抗逆转录病毒治疗的儿科艾滋病毒患者中,依非韦伦血浆浓度的变异性。
BMC Pharmacol Toxicol. 2018 Oct 23;19(1):66. doi: 10.1186/s40360-018-0258-6.
7
Safety, efficacy, and pharmacokinetics of single-tablet elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in virologically suppressed, HIV-infected children: a single-arm, open-label trial.单片复方埃替拉韦、考比司他、恩曲他滨和替诺福韦艾拉酚胺用于病毒学抑制的HIV感染儿童的安全性、疗效及药代动力学:一项单臂、开放标签试验
Lancet Child Adolesc Health. 2017 Sep;1(1):27-34. doi: 10.1016/S2352-4642(17)30009-3. Epub 2017 Jun 29.
8
Optimizing Research to Speed Up Availability of Pediatric Antiretroviral Drugs and Formulations.优化研究以加速儿科抗逆转录病毒药物和配方的供应。
Clin Infect Dis. 2017 Jun 1;64(11):1597-1603. doi: 10.1093/cid/cix194.
9
CYP2B6 genotype-directed dosing is required for optimal efavirenz exposure in children 3-36 months with HIV infection.对于3至36个月大的HIV感染儿童,需要根据CYP2B6基因型指导用药,以实现依非韦伦的最佳暴露量。
AIDS. 2017 May 15;31(8):1129-1136. doi: 10.1097/QAD.0000000000001463.
10
Pharmacists and Pediatric Medication Adherence: Bridging the Gap.药剂师与儿童用药依从性:弥合差距
Hosp Pharm. 2017 Feb;52(2):124-131. doi: 10.1310/hpj5202-124.

儿童和青少年的抗逆转录病毒疗法:现代单片复方制剂剖析

Antiretroviral Therapy in Children and Adolescents: A Look Into Modern Single Tablet Regimens.

作者信息

Lee Clara, Sapasap Jenna, LaRochelle Joseph, Smith Renata O, Badowski Melissa E

出版信息

J Pediatr Pharmacol Ther. 2021;26(8):783-794. doi: 10.5863/1551-6776-26.8.783. Epub 2021 Nov 10.

DOI:10.5863/1551-6776-26.8.783
PMID:34790067
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8591998/
Abstract

Single tablet regimens (STRs) have simplified antiretroviral therapy (ART) over the years in the adult human immunodeficiency virus (HIV) population. However, there is still a prevalent need to simplify regimens in children and adolescents living with HIV. Finding the optimal regimen requires a multi-factorial approach due to their complex pharmacokinetic profiles throughout childhood and the challenges and limitations of medication non-adherence in the pediatric population. These challenges include pill size, available formulations, palatability, and caregiver health literacy, which can all affect the proper administration of medications. The complexity of this population implies the importance of customizing everyone's antiretroviral regimen so that the patient and family can successfully adhere to the therapy. The current recommendations for ART in the adult and pediatric populations are similar, yet the use of STRs are limited. The goal of this review was to assess current data on available STRs and determine their utility as ART in the pediatric population.

摘要

多年来,单片复方制剂(STRs)简化了成人人类免疫缺陷病毒(HIV)感染者的抗逆转录病毒疗法(ART)。然而,对于感染HIV的儿童和青少年来说,仍普遍存在简化治疗方案的需求。由于儿童期复杂的药代动力学特征以及儿科人群中药物治疗依从性方面的挑战和限制,寻找最佳治疗方案需要采取多因素方法。这些挑战包括药丸大小、可用剂型、口感以及照顾者的健康素养,所有这些都会影响药物的正确服用。该人群的复杂性意味着为每个人定制抗逆转录病毒治疗方案非常重要,这样患者和家庭才能成功坚持治疗。目前成人和儿科人群抗逆转录病毒治疗的推荐方案相似,但单片复方制剂的使用有限。本综述的目的是评估现有单片复方制剂的当前数据,并确定其在儿科人群中作为抗逆转录病毒治疗的效用。